Luke Mountjoy

858 total citations
16 papers, 148 citations indexed

About

Luke Mountjoy is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luke Mountjoy has authored 16 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Hematology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luke Mountjoy's work include Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Luke Mountjoy is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), CAR-T cell therapy research (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Luke Mountjoy collaborates with scholars based in United States. Luke Mountjoy's co-authors include Mitesh J. Borad, Mohamad Bassam Sonbol, Kabir Mody, Tanios Bekaii‐Saab, Belal Firwana, Diana Almader‐Douglas, M. Hassan Murad, Daniel H. Ahn, Joleen M. Hubbard and Amik Sodhi and has published in prestigious journals such as New England Journal of Medicine, Blood and JAMA Oncology.

In The Last Decade

Luke Mountjoy

14 papers receiving 146 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Mountjoy United States 7 86 32 28 26 20 16 148
Maria Anna Siciliano Italy 7 80 0.9× 17 0.5× 55 2.0× 26 1.0× 26 1.3× 12 176
Konstantinos Christofyllakis Germany 6 64 0.7× 26 0.8× 31 1.1× 8 0.3× 13 0.7× 30 149
H. Riess Germany 6 87 1.0× 31 1.0× 31 1.1× 18 0.7× 8 0.4× 11 150
Andreas Jakob Germany 8 94 1.1× 37 1.2× 74 2.6× 13 0.5× 31 1.6× 21 177
Suchitra Sundaram United States 7 54 0.6× 15 0.5× 22 0.8× 11 0.4× 19 0.9× 25 148
Shalin Kothari United States 6 34 0.4× 18 0.6× 17 0.6× 9 0.3× 22 1.1× 23 104
Nicolas Gallastegui United States 6 95 1.1× 28 0.9× 34 1.2× 13 0.5× 73 3.6× 14 209
Jean‐François Tamby United States 4 63 0.7× 9 0.3× 29 1.0× 40 1.5× 20 1.0× 9 170
Kenta Nio Japan 7 117 1.4× 5 0.2× 37 1.3× 36 1.4× 35 1.8× 28 169
Telma Santos Brazil 4 68 0.8× 31 1.0× 133 4.8× 29 1.1× 8 0.4× 10 215

Countries citing papers authored by Luke Mountjoy

Since Specialization
Citations

This map shows the geographic impact of Luke Mountjoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Mountjoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Mountjoy more than expected).

Fields of papers citing papers by Luke Mountjoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Mountjoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Mountjoy. The network helps show where Luke Mountjoy may publish in the future.

Co-authorship network of co-authors of Luke Mountjoy

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Mountjoy. A scholar is included among the top collaborators of Luke Mountjoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Mountjoy. Luke Mountjoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Hilal, Talal & Luke Mountjoy. (2023). Allogeneic Hematopoietic Stem Cell Transplant for Diffuse Large B-Cell Lymphoma: Evolving Role in the Era of CAR T-Cell Therapy. Current Oncology Reports. 25(6). 599–607. 1 indexed citations
2.
Sauter, Craig S., Gautam Borthakur, Luke Mountjoy, et al.. (2023). A Phase 1 Study of NKX101, a Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy, with Fludarabine and Cytarabine in Patients with Acute Myeloid Leukemia. Blood. 142(Supplement 1). 2097–2097. 17 indexed citations
3.
Goy, André, Caron A. Jacobson, Ian W. Flinn, et al.. (2023). Outcomes of Patients with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Treated with Brexucabtagene Autoleucel (Brexu-cel) in ZUMA-2 and ZUMA-18, an Expanded Access Study. Blood. 142(Supplement 1). 106–106. 6 indexed citations
4.
Skarbnik, Alan P, Luke Mountjoy, Zaw Myint, et al.. (2022). Trial in Progress: First Report of the Phase 1/2 Study of the Safety and Efficacy of CPO107, a Bispecific Agent Targeting CD20/CD47 in CD20 Expressing Non-Hodgkin Lymphoma (NHL). Blood. 140(Supplement 1). 12059–12060. 3 indexed citations
5.
6.
Mountjoy, Luke, et al.. (2020). Mortality and Glycemic Control Among Patients with Acute and Chronic Myeloid Leukemia and Diabetes: A Case–Control Study. Future Science OA. 7(1). FSO639–FSO639. 1 indexed citations
7.
Jain, Tania, Katie L. Kunze, Luke Mountjoy, et al.. (2020). Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis. Blood Cancer Journal. 10(3). 36–36. 13 indexed citations
8.
Sharma, Akanksha, et al.. (2020). Psychiatric Disturbance or Parkinsonism as a Presentation of CNS Lymphoma: Observational Retrospective Study and Review of Literature. American Journal of Clinical Oncology. 43(10). 727–733. 2 indexed citations
9.
González-Vélez, Miguel, Heidi Kosiorek, Richard Butterfield, et al.. (2020). Improving the Definition of Response Assessment: Prognostic Value of Minimal Residual Disease Combined with PET/CT at Day 100 Post Autologous Stem Cell Transplantation in Multiple Myeloma. Blood. 136(Supplement 1). 33–34. 1 indexed citations
10.
Mountjoy, Luke, Jeanne Palmer, Katie L. Kunze, et al.. (2020). Does early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantation?. Leukemia & lymphoma. 62(1). 252–254. 7 indexed citations
11.
Mountjoy, Luke, Tania Jain, Katie L. Kunze, et al.. (2020). Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation. Leukemia & lymphoma. 61(8). 1996–2002. 7 indexed citations
12.
Sonbol, Mohamad Bassam, Luke Mountjoy, Belal Firwana, et al.. (2019). The Role of Maintenance Strategies in Metastatic Colorectal Cancer. JAMA Oncology. 6(3). e194489–e194489. 69 indexed citations
13.
Sharma, Akanksha, Luke Mountjoy, Richard Butterfield, et al.. (2019). Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer. American Journal of Clinical Oncology. 43(2). 128–132. 3 indexed citations
14.
Sharma, Akanksha, Natalie Ertz-Archambault, Luke Mountjoy, Alyx B. Porter, & Maciej M. Mrugała. (2018). Psychiatric Disturbance As a Presenting Symptom in Central Nervous Lymphoma. Blood. 132(Supplement 1). 5415–5415.
15.
Mountjoy, Luke & Daniel R. Kollmorgen. (2017). Glucagonoma-Associated Rash. New England Journal of Medicine. 376(10). e18–e18. 4 indexed citations
16.
Mountjoy, Luke, Robert J. Schneider, Hayden L. Smith, et al.. (2017). Atrio-Esophageal Fistula: A Case Series and Literature Review. American Journal of Case Reports. 18. 847–854. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Anna Siciliano Breakdown of academic impact, for papers by Konstantinos Christofyllakis Breakdown of academic impact, for papers by H. Riess Breakdown of academic impact, for papers by Andreas Jakob Breakdown of academic impact, for papers by Suchitra Sundaram Breakdown of academic impact, for papers by Shalin Kothari Breakdown of academic impact, for papers by Nicolas Gallastegui Breakdown of academic impact, for papers by Jean‐François Tamby Breakdown of academic impact, for papers by Kenta Nio Breakdown of academic impact, for papers by Telma Santos
Rankless by CCL
2026